REG - IXICO plc - Director/PDMR Shareholding
RNS Number : 6513AIXICO plc23 January 2020
23 January 2020
IXICO plc
("IXICO" or the "Company")
Director and PDMR share purchase
IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, announces that it received notification on 22 January 2020 that on 21 January 2020 Giulio Cerroni, CEO of the Company, acquired 24,800 ordinary shares at an aggregated price of £0.802.
Giulio Cerroni is interested in 109,600 Ordinary Shares, representing 0.23 per cent of the issued share capital of the Company following the purchase.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Giulio Cerroni
2
Reason for the notification
a)
Position/status
CEO (PDMR)
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
IXICO plc
b)
LEI
2138005M1F59O6HWSA97
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares in IXICO plc
Identification code
GB00BCLY7L40
b)
Nature of the transaction
Acquisition
c)
Price(s) and volume(s)
Price(s)
Volume(s)
21/01/2020
£0.802
24,800
d)
Aggregated information
- Aggregated volume
24,800 shares
- Price
£0.802
e)
Date of the transaction
21/01/2020
f)
Place of the transaction
London Stock Exchange, AIM Market (IXI), UK
For further information please contact:
IXICO plc
Giulio Cerroni, Chief Executive Officer
+44 (0) 20 3763 7499
Grant Nash, Chief Financial Officer
Cenkos Securities PLC (Nominated adviser and sole broker)
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
+44 (0) 20 7397 8900
Optimum Strategic Communications
Mary Clark, Supriya Mathur, Manel Mateus
IXICO@optimumcomms.com
+44 (0) 203 950 9144
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHDLLFLBFLEBBF
Recent news on IXICO
See all newsREG - IXICO plc - Trading Update
AnnouncementREG - IXICO plc - Share option awards and PDMR Dealing
AnnouncementREG - IXICO plc - FDA Clearance of Alzheimer's Diagnostic Biomarker
AnnouncementREG - IXICO plc - Holding(s) in Company
AnnouncementREG - IXICO plc - Half-year Report
Announcement